Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL924501

CC(=O)Nc1nc(C)c(-c2ccc(Cl)nc2)s1.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 14/20 0.55
PIK3CA P42336 11/20 0.55
PIK3CD O00329 11/20 0.55
PIK3CB P42338 10/20 0.55
PI4KB Q9UBF8 5/20 0.50
PIK3C2A O00443 2/20 0.50
PIK3C2B O00750 2/20 0.50
STK17A Q9UEE5 2/20 0.50
RPS6KA4 O75676 1/20 0.50
CYP3A4 P08684 1/20 0.50
DYRK3 O43781 1/20 0.49
MAP4K4 O95819 1/20 0.49
CDK9 P50750 1/20 0.49
MAP4K2 Q12851 1/20 0.49
PIK3C3 Q8NEB9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL925027 0.92 PIK3CG (0.64) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL924839 0.88 PIK3CG (0.56) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL924339 0.85 PIK3CG (0.55) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL924503 0.80 PI4KB (0.48) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL924622 0.80 PIK3CG (0.64) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL924653 0.78 PIK3CB (0.62) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL924742 0.78 PIK3CB (0.87) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL926553 0.78 PIK3CA (0.59) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL924714 0.77 RIPK1 (0.65) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
Trifluoroacetic Acid SCHEMBL926036 0.76 PIK3CB (0.90) PIK3CGPIK3CAPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868188-B2 5-heteroaryl thiazoles and their use as PI3K inhibitors ASTRAZENECA AB (SE) 2011-01-11 US disclosed
EP-1841763-B1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2010-06-30 EP disclosed
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors MTOR, PIK3R5, PIK3CA PIK3CG 16/4885PIK3CA 3/4885PIK3CD 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.